Jawaharlal Institute of Postgraduate Medical Education and Research   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Pondicherry India (1823)

Organization Overview

First Clinical Trial
2009
NCT01454609
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Jawaharlal Institute of Postgraduate Medical Education and Research | Jawaharlal Institute of Postgraduate Medical Education & Research | Professor, Dept. of Surgery, JIPMER

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Rheumatoid (Phase 4)

Hematoma (Phase 4)

Hematoma, Subdural (Phase 4)

Hematoma, Subdural, Acute (Phase 4)

Lupus Nephritis (Phase 4)

Nephritis (Phase 4)

Pain, Postoperative (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Insufficiency (Phase 4)

Snake Bites (Phase 4)

Syndrome (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 33